Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Collplant Biotechnologies Ltd ADR (CLGN)

Collplant Biotechnologies Ltd ADR (CLGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 95,710
  • Shares Outstanding, K 5,670
  • Annual Sales, $ 6,140 K
  • Annual Income, $ -5,770 K
  • 60-Month Beta N/A
  • Price/Sales 8.12
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CLGN with:

Options Overview

Details
  • Implied Volatility 104.34%
  • Historical Volatility 35.50%
  • IV Percentile 83%
  • IV Rank 100.00%
  • IV High 104.34% on 09/16/21
  • IV Low 5.58% on 09/13/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 3
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 0

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.10
  • Number of Estimates 2
  • High Estimate 0.08
  • Low Estimate -0.27
  • Prior Year 0.07
  • Growth Rate Est. (year over year) -242.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.00 +5.50%
on 08/19/21
18.58 -9.15%
on 08/27/21
-1.16 (-6.43%)
since 08/16/21
3-Month
16.00 +5.50%
on 08/19/21
23.49 -28.14%
on 06/23/21
-3.62 (-17.66%)
since 06/16/21
52-Week
6.00 +181.33%
on 11/05/20
24.26 -30.42%
on 02/11/21
+8.13 (+92.91%)
since 09/16/20

Most Recent Stories

More News
CollPlant CEO Yehiel Tal elected to the Board of Directors of the International Society for Biofabrication (ISBF)

REHOVOT, , /PRNewswire/ --  (NASDAQ: CLGN),a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced...

CLGN : 16.88 (-0.65%)
CollPlant To Present at the H.C. Wainwright Annual Global Investment Conference in September

REHOVOT, , /PRNewswire/ --  (NASDAQ: CLGN),a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced...

CLGN : 16.88 (-0.65%)
CollPlant Appoints Medical Aesthetics Veteran Alisa Lask to Board of Directors

REHOVOT, , /PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, announced...

CLGN : 16.88 (-0.65%)
CollPlant Biotechnologies Provides Business Updates and Second Quarter 2021 Financial Results

REHOVOT, , /PRNewswire/ -- (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced...

CLGN : 16.88 (-0.65%)
CollPlant Biotechnologies to Present on the Use of Collagen BioInk as a Platform for 3D Bioprinting of Tissues and Organs at the Biomaterials For 3D Printing Webinar

REHOVOT, , /PRNewswire/ - CollPlant (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today...

CLGN : 16.88 (-0.65%)
3D Systems (DDD) Joins CollPlant for Bioprinted Breast Tissue Matrix

The collaborative efforts of 3D Systems (DDD) and CollPlant aim to eliminate the odds of adverse immune response in the human body induced by procedures using tissue derived from humans and animals.

UTHR : 205.14 (+0.43%)
DDD : 30.63 (+1.76%)
SIMO : 75.75 (+0.50%)
CLGN : 16.88 (-0.65%)
3D Systems and CollPlant Enter Co-development Agreement to Deliver Bioprinted Solutions for Improved Breast Reconstruction Treatments

Today, 3D Systems (NYSE:DDD) and CollPlant Biotechnologies (NASDAQ:CLGN) announced they have signed a co-development agreement for a 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction...

DDD : 30.63 (+1.76%)
CLGN : 16.88 (-0.65%)
CollPlant Announces Effectiveness of Uplisting to the Nasdaq Global Market®; Ordinary Shares Replace ADSs

REHOVOT, , /PRNewswire/ -- a regenerative and aesthetic medicine company, announced today the uplisting of its ordinary shares to the Nasdaq Global Select Market®  effective at the open of market today,...

CLGN : 16.88 (-0.65%)
CollPlant Biotechnologies Reports First Quarter 2021 Financial Results with Record Revenues of $14.5 Million

REHOVOT, , /PRNewswire/ -- (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced financial results for the first quarter ended and provided an update on the Company's business...

CLGN : 16.88 (-0.65%)
CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) Outpaces Stock Market Gains: What You Should Know

CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) closed at $14.68 in the latest trading session, marking a +1.91% move from the prior day.

CLGN : 16.88 (-0.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

CollPlant Biotechnologies Ltd. is a regenerative medicine company. It is focused on 3D bioprinting of tissues and organs, medical aesthetics and on developing and commercializing tissue repair products for orthobiologics and advanced wound care markets. CollPlant Biotechnologies Ltd., formerly knonw...

See More

Key Turning Points

3rd Resistance Point 16.88
2nd Resistance Point 16.88
1st Resistance Point 16.88
Last Price 16.88
1st Support Level 16.88
2nd Support Level 16.88
3rd Support Level 16.88

See More

52-Week High 24.26
Fibonacci 61.8% 17.28
Last Price 16.88
Fibonacci 50% 15.13
Fibonacci 38.2% 12.98
52-Week Low 6.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar